Is APOE useful for Wechseljahre?

APOE is primarily known for its association with Alzheimer's disease risk, especially the ε4 allele. During menopause, estrogen decline can affect cognitive function, and some research suggests APOE-ε4 carriers may be more vulnerable to cognitive changes. However, the evidence is not robust enough to recommend APOE testing for menopause management. Consumer DNA tests like MyBody-X provide only a risk estimate, not a diagnosis. For typical menopausal symptoms (hot flashes, sleep issues, mood changes), hormone therapy, lifestyle modifications, and targeted supplements have stronger evidence. APOE testing is not standard in menopause care. The effect of a single SNP is small and context-dependent. Consult a healthcare provider before making any decisions based on such results.